Open Access
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Giles Dixon, Samuel Hague, Sarah Mulholland, Huzaifa Adamali, Aye Myat Noe Khin, Hannah Thould, Roisin Connon, Paul Minnis, Eoin Murtagh, Fasihul Khan, Sameen Toor, Alexandra Lawrence, Marium Naqvi, Alex West, Robina K. Coker, Katie Ward, Leda Yazbeck, Simon Hart, Theresa Garfoot, Kate Newman, Pilar Rivera-Ortega, Lachlan Stranks, Paul Beirne, Jessica Bradley, Catherine Rowan, Sarah Agnew, Mahin Ahmad, Lisa G. Spencer, Joshua Aigbirior, Ahmed Fahim, Andrew M. Wilson, Elizabeth Butcher, Sy Giin Chong, Gauri Saini, Sabrina Zulfikar, Felix Chua, Peter M. George, Maria Kokosi, Vasileios Kouranos, Philip Molyneaux, Elisabetta Renzoni, Benedetta Vitri, Athol U. Wells, Lisa M. Nicol, Stephen Bianchi, Raman Kular, HuaJian Liu, Alexander John, Sarah Barth, Melissa Wickremasinghe, Ian A. Forrest, Ian Grimes, A. John Simpson, Sophie V. Fletcher, Mark G. Jones, Emma Kinsella, Jennifer Naftel, Nicola Wood, Jodie Chalmers, Anjali Crawshaw, Louise E. Crowley, Davinder Dosanjh, Christopher C. Huntley, Gareth I. Walters, Timothy Gatheral, Catherine Plum, Shiva Bikmalla, Raja Muthusami, Helen Stone, Jonathan C.L. Rodrigues, Krasimira Tsaneva-Atanasova, Chris J. Scotton, Michael A. Gibbons, Shaney L. Barratt
ERJ Open Res 10: 00529-2023; DOI: 10.1183/23120541.00529-2023 Published 15 January 2024